Agios Pharmaceuticals (AGIO) Stock: Buy, Sell, or Hold?
AGIO - Agios Pharmaceuticals, Inc.
$33.60
-0.04 (-0.12%)
âŧ
5d:
+1.42%
30d:
-1.78%
90d:
+16.99%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Get Alerted When AGIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: AGIO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: AGIO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: AGIO is currently trading at $33.60, which is considered fair relative to its 30-day fair value range of $32.56 to $34.27.
Technical Outlook: Technically, AGIO is in a uptrend. Immediate support is located at $32.23, while resistance sits at $35.38.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $45.75 (+36.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AGIO is in a uptrend. Immediate support is located at $32.23, while resistance sits at $35.38.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $45.75 (+36.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$32.56 -
$34.27
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.2% below Wall St target ($45.75)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$32.56 -
$34.27
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$32.23
Resistance Level
$35.38
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.11
Wall Street Target
$45.75
(+36.2%)
Revenue Growth (YoY)
259.3%
Share & Embed Analysis
Last updated: September 12, 2026 6:40 AM ET
Data refreshes hourly during market hours. Next update: 7:40 AM
Data refreshes hourly during market hours. Next update: 7:40 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
James William Burns
SELL
3280 shares
2026-04-02
Sarah Gheuens
SELL
2940 shares
2026-04-02
Tsveta Milanova
SELL
3262 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 56 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 60 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 57 HOLD |
|
RNA
Atrium Therapeutics, IncâĻ |
STRONG BUY
15 analysts |
$25 | 55 HOLD |
